
Roberto Galea
Latest contributions
LAA closure and anthrombotic therapies
21 May 2025 – From EuroPCR 2025
Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, diabetes, obesity, and a history of pacemaker implantation in 2023, presented with retinal hemorrhage while on NACO for AF. Despite a CHA2DS2-VASC score of 5, anticoagulation was withdrawn. The operators implanted a Watchman device in the LAA via a venous right femoral...

Challenging LAA occlusion cases
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios in left atrial appendage (LAA) occlusion procedures. Participants will learn about techniques for rescuing a migrating LAA occluder, managing incomplete surgical LAA ligation, and utilizing specialized techniques like the "kissing" approach for LAA...

One-year outcomes after Amulet or Watchman/FLX device for percutaneous left atrial appendage closure: a pre-specified analysis of the SWISS-APERO randomized clinical trial
30 Oct 2023
Alex Sticchi interviews Roberto Galea on the 1-year results of the SWISS-APERO randomized clinical trial, which he presented at TCT Congress 2023 in San Francisco.

Author

Author

Stroke preventing interventions: pitfalls and complication management
18 May 2022 – From EuroPCR 2022
Watch this session on LAA closure to discover various ways to manage some pitfalls and complications, such as a massive air embolism, a rare source of thromboembolism, and more!

Stroke prevention and diagnosis
18 May 2022 – From EuroPCR 2022
Watch these videos on stroke prevention and diagnosis to learn more about the impact of pre-procedural CT on LAAC outcomes, the sex differences in safety and effectiveness of LAA closure, the temporal changes and clinical significance of peri-device leak following LAAO, and more!

Innovative devices for innovative procedures
17 May 2022 – From EuroPCR 2022
This session focuses on innovations to invent or improve therapeutic modalities in the cath lab based on unmet needs in PCI, LAAO, CHF interventions, intravascular imaging and therapeutics, TAVI, and peripheral vascular interventions.
